MedTrace Logo

Evaluation of the Effects of Simvastatin 40mg

NCT00397826 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-01-07

No results posted yet for this study

Summary

To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.

Conditions

Interventions

DRUG

MK0733

Duration of Treatment: 12 Weeks

Sponsors & Collaborators

  • Cardinal Tien Hospital

    lead OTHER

Principal Investigators

  • Dong Feng Yeih, MD,Phd · Cardinal Tiem Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-01-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00397826 on ClinicalTrials.gov